The protein landscape of chronic lymphocytic leukemia.

Autor: Meier-Abt F; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.; Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.; Institute of Medical Genetics, University of Zurich, Zurich, Switzerland., Lu J; European Molecular Biology Laboratory, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany., Cannizzaro E; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland., Pohly MF; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland., Kummer S; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland., Pfammatter S; Functional Genomics Center Zurich, ETH/University of Zurich, Zurich, Switzerland., Kunz L; Functional Genomics Center Zurich, ETH/University of Zurich, Zurich, Switzerland., Collins BC; School of Biological Sciences, Queen's University, Belfast, United Kingdom., Nadeu F; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Lee KS; National Center for Tumor Diseases, Heidelberg, Germany., Xue P; Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland., Gwerder M; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland., Roiss M; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland., Hüllein J; National Center for Tumor Diseases, Heidelberg, Germany., Scheinost S; National Center for Tumor Diseases, Heidelberg, Germany., Dietrich S; Molecular Medicine Partnership Unit, Heidelberg, Germany.; University Hospital Heidelberg, Heidelberg, Germany., Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.; Hematopathology Section, Laboratory of Pathology, Hospital Clinic of Barcelona, Barcelona, Spain; and., Huber W; European Molecular Biology Laboratory, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany., Aebersold R; Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.; Faculty of Science, University of Zurich, Zurich, Switzerland., Zenz T; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.

Publikováno v: Blood [Blood] 2021 Dec 16; Vol. 138 (24), pp. 2514-2525.

Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets.

Autor: Griffen, Ti'ara L., Hoff, Fieke W., Qiu, Yihua, Lillard Jr., James W., Ferrajoli, Alessandra, Thompson, Philip, Toro, Endurance, Ruiz, Kevin, Burger, Jan, Wierda, William, Kornblau, Steven M.

Publikováno v: Blood Cancer Journal; Mar2022, Vol. 12 Issue 3, p1-14, 14p